Effect of Ozonated Gel Phonophoresis on Pain and Functional Disability in Patients With Chronic S… (NCT07316738) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effect of Ozonated Gel Phonophoresis on Pain and Functional Disability in Patients With Chronic Supraspinatus Tendinitis
Egypt40 participantsStarted 2025-12-25
Plain-language summary
This study will be conducted to investigate the effect of ozonated gel phonophoresis on pain intensity, shoulder joint range of motion, and functional disability in patients with chronic supraspinatus tendinitis grades I and II.
Who can participate
Age range30 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients from 30-60 years old from both genders.
* The patients will be assigned to the study will be diagnosed with grade I or II supraspinatus tendinitis based on Neer's classification.
* The patients suffered from supraspinatus tendinitis for more than 3 months and taking non-steroidal anti-inflammatory drugs suggested by orthopedist.
* All patients have body mass index between 18.5 and 29.9 kg/m2.
Exclusion Criteria:
* Grades III of supraspinatus tendinitis. (Bone spurs and tendon rapture)
* Any past shoulder surgical interventions. (Rotator cuff repair, labrum tear and open reduction internal fixation)
* Shoulder joint instability
* Shoulder fracture.
* Non-cooperative subjects.
* Neuromuscular diseases (spinal muscular atrophy, whiplash injury)
* Cardiovascular disease.
* History of cancer.
* Systemic diseases such as rheumatoid arthritis, Reiter's syndrome, or diabetes.
* Severe medical and neurological or psychiatric disorders.
* Pregnant and lactating women.